The case–control study between the Italian patients with NAFLD and 316 healthy Italian controls found no protective effect of the APOC3 wild type, and no significant association with histological characteristics or NASH diagnosis was observed. This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.